CANY
NOV icon

Caxton Associates (New York)’s NOV NOV Stock Holding History

Caxton Associates (New York)’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-91,300
Closed -$1.46M – 612
2024
Q3 		$1.46M Buy
+91,300
New +$1.62M 0.05% 179
2022
Q3 		– Sell
-62,307
Closed -$1.05M – 611
2022
Q2 		$1.05M Buy
+62,307
New +$1.17M 0.1% 113
2014
Q2 		– Sell
-44,360
Closed -$3.12M – 233
2014
Q1 		$3.12M Buy
+44,360
New +$3.04M 0.19% 93

Other funds holding NOV

Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (New York)'s NOV Position: Q4 2024 in Review

Caxton Associates (New York) sold out of NOV (NOV) in Q4 2024, closing a stake of 91,300 shares — an estimated $1.46M sold.

Caxton Associates (New York) first reported a position in NOV in Q1 2014 and held it in 3 quarters. The position peaked at $3.12M in Q1 2014. 433 funds tracked by Wall St. Rank hold NOV as of Q4 2024.

  • Caxton Associates (New York) reported no remaining NOV position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 91,300 NOV shares in Q4 2024, an estimated $1.46M.
  • Caxton Associates (New York) first reported a position in NOV in Q1 2014 and held it in 3 quarters.
  • Caxton Associates (New York)'s NOV position peaked at $3.12M in Q1 2014.
  • 433 funds tracked by Wall St. Rank held NOV as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.